Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
CA 2470612 A1 · Owner: Huang, Dehua · Inventors: Cosford, Nicholas D. P.; Huang, Dehua; Smith, Nicholas D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Imidazole compounds substituted directly or by a bridge, with a heteroaryl , moiety containing N adjacent to the point of connection of the heteroaryl are , mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety depression, bipolar disorder and , panic as well as in the treatment of pain, circadian rhythm disorders and , other diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.